Angarus Therapeutics, Inc.

Biotechnology company · Portola Valley, California, United States

Angarus Therapeutics, Inc. is a biotechnology company headquartered in Portola Valley, California, United States. Its earliest recorded incorporation is in 2018. It has reported private securities offerings to the US SEC, most recently $11 million sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

Angarus Therapeutics at a glance

Typebiotechnology company
HeadquartersPortola Valley, California, United States
Earliest incorporation on record2018
SEC CIK1836891

What does Angarus Therapeutics do?

Private fundraising reported to the SEC

4 Form D notices; the most recent reported $11.3 million sold (2021).

Frequently asked questions about Angarus Therapeutics

Where is Angarus Therapeutics headquartered?

Angarus Therapeutics, Inc. is headquartered in Portola Valley, California, United States.

What does Angarus Therapeutics do?

Angarus Therapeutics, Inc. is a biotechnology company.

When was Angarus Therapeutics founded?

The earliest incorporation on record for Angarus Therapeutics, Inc. is in 2018, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences